Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study to Evaluate the Effect of Nasal Carbon Dioxide on Nasal Congestion Via Acoustic Rhinometry in Subjects With Perennial Allergic Rhinitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jul 2017
Price :
$35
*
At a glance
- Drugs Carbon dioxide (Primary)
- Indications Perennial allergic rhinitis
- Focus Therapeutic Use
- Sponsors Capnia
- 03 Feb 2016 New trial record